BioMérieux Buys Argene for up to $60.1M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioMérieux today announced it has purchased French firm Argene for up to €42.5 million ($60.1 million).

BioMérieux is acquiring all of the shares of Ab-Services, the holding firm that owns Argene, for €37.5 million upfront and may make up to €5 million in contingent payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.